<VariationArchive VariationID="960238" VariationName="NM_000194.3(HPRT1):c.564del (p.Val188_Val189insTer)" VariationType="Deletion" Accession="VCV000960238" Version="6" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2020-07-16" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="951616" VariationID="960238">
      <GeneList>
        <Gene Symbol="HPRT1" FullName="hypoxanthine phosphoribosyltransferase 1" GeneID="3251" HGNC_ID="HGNC:5157" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq26.2-26.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="134460165" stop="134500668" display_start="134460165" display_stop="134500668" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="133594174" stop="133634697" display_start="133594174" display_stop="133634697" Strand="+" />
          </Location>
          <OMIM>308000</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HPRT1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HPRT1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000194.3(HPRT1):c.564del (p.Val188_Val189insTer)</Name>
      <CanonicalSPDI>NC_000023.11:134498637:TT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq26.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="134498638" stop="134498638" display_start="134498638" display_stop="134498638" variantLength="1" positionVCF="134498637" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="133632668" stop="133632668" display_start="133632668" display_stop="133632668" variantLength="1" positionVCF="133632667" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.133632669del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.133632669del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.134498639del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.134498639del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012329.2" sequenceAccession="NG_012329" sequenceVersion="2" change="g.43495del">
            <Expression>NG_012329.2:g.43495del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000194.3" sequenceAccession="NM_000194" sequenceVersion="3" change="c.564del" MANESelect="true">
            <Expression>NM_000194.3:c.564del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000185.1" sequenceAccession="NP_000185" sequenceVersion="1" change="p.Val188_Val189insTer">
            <Expression>NP_000185.1:p.Val188_Val189insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2077687660" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000194.3(HPRT1):c.564del (p.Val188_Val189insTer) AND multiple conditions" Accession="RCV001233727" Version="6">
        <ClassifiedConditionList TraitSetID="10191">
          <ClassifiedCondition DB="MedGen" ID="C0023374">Lesch-Nyhan syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0268117">Partial hypoxanthine-guanine phosphoribosyltransferase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-03" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-07-16" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">9799086</ID>
        </Citation>
        <DescriptionHistory Dated="2024-02-25">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="10191" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5209" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Partial hypoxanthine-guanine phosphoribosyltransferase deficiency</ElementValue>
                <XRef ID="Partial+hypoxanthine-guanine+phosphoribosyltransferase+deficiency/9096" DB="Genetic Alliance" />
                <XRef ID="238007004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HPRT DEFICIENCY, PARTIAL</ElementValue>
                <XRef Type="MIM" ID="300323" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HPRT1 DEFICIENCY, PARTIAL</ElementValue>
                <XRef Type="MIM" ID="300323" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE 1 DEFICIENCY, PARTIAL</ElementValue>
                <XRef Type="MIM" ID="300323" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GOUT, HPRT-RELATED</ElementValue>
                <XRef Type="MIM" ID="300323" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16710" />
                <XRef ID="16710" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">HPRT1 disorders, caused by deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGprt), are typically associated with clinical evidence for overproduction of uric acid (hyperuricemia, nephrolithiasis, and/or gouty arthritis) and varying degrees of neurologic and/or behavioral problems. Historically, three phenotypes were identified in the spectrum of HPRT1 disorders: Lesch-Nyhan disease (LND) at the most severe end with motor dysfunction resembling severe cerebral palsy, intellectual disability, and self-injurious behavior; HPRT1-related neurologic dysfunction (HND) in the intermediate range with similar but fewer severe neurologic findings than LND and no self-injurious behavior; and HPRT1-related hyperuricemia (HRH) at the mild end without overt neurologic deficits. It is now recognized that these neurobehavioral phenotypes cluster along a continuum from severe to mild.</Attribute>
                <XRef ID="NBK1149" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301328</ID>
                <ID Source="BookShelf">NBK1149</ID>
              </Citation>
              <XRef ID="79233" DB="Orphanet" />
              <XRef ID="C0268117" DB="MedGen" />
              <XRef ID="MONDO:0010299" DB="MONDO" />
              <XRef Type="MIM" ID="300323" DB="OMIM" />
            </Trait>
            <Trait ID="5397" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Lesch-Nyhan syndrome</ElementValue>
                <XRef ID="Lesch+Nyhan+syndrome/4181" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010298" DB="MONDO" />
                <XRef ID="10406007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LNS</ElementValue>
                <XRef Type="MIM" ID="300322" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7226" />
                <XRef ID="7226" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">HPRT1 disorders, caused by deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGprt), are typically associated with clinical evidence for overproduction of uric acid (hyperuricemia, nephrolithiasis, and/or gouty arthritis) and varying degrees of neurologic and/or behavioral problems. Historically, three phenotypes were identified in the spectrum of HPRT1 disorders: Lesch-Nyhan disease (LND) at the most severe end with motor dysfunction resembling severe cerebral palsy, intellectual disability, and self-injurious behavior; HPRT1-related neurologic dysfunction (HND) in the intermediate range with similar but fewer severe neurologic findings than LND and no self-injurious behavior; and HPRT1-related hyperuricemia (HRH) at the mild end without overt neurologic deficits. It is now recognized that these neurobehavioral phenotypes cluster along a continuum from severe to mild.</Attribute>
                <XRef ID="NBK1149" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301328</ID>
                <ID Source="BookShelf">NBK1149</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="pmc">3111012</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3039492</ID>
              </Citation>
              <XRef ID="510" DB="Orphanet" />
              <XRef ID="C0023374" DB="MedGen" />
              <XRef ID="MONDO:0010298" DB="MONDO" />
              <XRef Type="MIM" ID="300322" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2741360" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="6987328|MedGen:C0023374;C0268117" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001406335" DateUpdated="2024-02-28" DateCreated="2020-07-16" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9799086</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Val189*) in the HPRT1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 30 amino acid(s) of the HPRT1 protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with HPRT1-related conditions (Invitae). ClinVar contains an entry for this variant (Variation ID: 960238). This variant disrupts a region of the HPRT1 protein in which other variant(s) (p.His204Tyr) have been determined to be pathogenic (PMID: 9799086; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HPRT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.133632668del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0023374" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268117" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2741360" TraitType="Disease" MappingType="XRef" MappingValue="C0023374" MappingRef="MedGen">
        <MedGen CUI="C0023374" Name="Lesch-Nyhan syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2741360" TraitType="Disease" MappingType="XRef" MappingValue="C0268117" MappingRef="MedGen">
        <MedGen CUI="C0268117" Name="Partial hypoxanthine-guanine phosphoribosyltransferase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

